August 13, 2020- Aetion
In a recent interview, Kathryn Starzyk, epidemiologist and Head of Real-World Evidence (RWE) at OM1, shared what makes OM1’s data unique, and how she and her team partner with biopharma and health systems to generate RWE that helps researchers better understand patient journeys in disease areas including rheumatology and immunology.
Read on to hear more from Kathryn, including how she supports biopharma clients as they adopt RWE, and how RWD can inform the understanding of COVID-19’s impact on chronic disease management.